Jayant Bagai, MD

Original Contribution

Efficacy and Safety of Percutaneous Life Support During High-Risk Percutaneous Coronary Intervention, Refractory Cardiogenic Shock and In-Laboratory Cardiopulmonary Arrest

03/25/2011

David Webb , MS, CCP;

Marshall Crenshaw , MD;

David X. Zhao , MD;

Ehab S. Kasasbeh , MD;

Joseph G. Salloum , MD;

Jack P. Chen , MD, FACC, FSCAI, FCCP;

Jayant Bagai , MD;

ABSTRACT: Background. High-risk percutaneous coronary interventions (PCI), refractory cardiogenic shock and in-lab cardiac arrest are all associated with significant mortality. Percutaneous left ventricular assist devices (pLVAD) and CPS...

ABSTRACT: Background. High-risk...

03/25/2011

Journal of Invasive Cardiology

Cardiogenic Shock Management: International Survey of Contemporary Practices

09/30/2020

Yader Sandoval , MD;

Jose P.S. Henriques , MD, PhD;

Stavros G. Drakos , MD, PhD;

Iosif Taleb , MD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Jayant Bagai , MD;

Yiannis S. Chatzizisis , MD, PhD;

Benjamin Sun , MD;

Katarzyna Hryniewicz-Czeneszew , MD;

Peter M. Eckman , MD;

Holger Thiele , MD, PhD;

Mauricio G. Cohen , MD, FACC;

Angie S. Lobo , MD;

Limited data exist on current cardiogenic shock (CS) management strategies. We distributed a 48-question survey on the diagnosis and management of CS. Our survey suggests opportunities for standardization of care.

Limited data exist on current...

09/30/2020

Journal of Invasive Cardiology